DECIPHER LABS Fact Sheet, DECIPHER LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS Fact Sheet    (CMDG)


Alert: Discover the Makings of Potential 'Crorepati' Stocks from Richa Agarwal


Here is the latest financial fact sheet of DECIPHER LABS. For more details, see the DECIPHER LABS quarterly results and DECIPHER LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

DECIPHER LABS Price History

Price Rs 52.1
Mkt Cap Rs m 526
Vol '000 33.0
P/E X 4.6
P/CF X 23.7
EPS (TTM) Rs 11.3
1 Day % 4.9
No. of shares m 10.10
1 Week % 33.1
1 Month % -3.9
1 Year % 43.4
52 week H/L Rs 145.7/27.0
As on May 20, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DECIPHER LABS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DECIPHER LABS EQUITY SHARE DATA
High Rs1227313441 
Low Rs37171618 
Sales per share (Unadj.) Rs0.51.310.123.755.0 
Earnings per share (Unadj.) Rs-0.20.20.51.11.4 
Diluted earnings per shareRs-0.20.20.41.11.4 
Cash flow per share (Unadj.) Rs-0.20.20.51.62.2 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs2.42.73.212.413.6 
Adj. book value per shareRs1.92.12.512.413.6 
Shares outstanding (eoy) m8.008.008.0010.1010.10 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x16.213.72.41.10.5 
Avg P/E ratio x-33.076.447.923.121.3 
P/CF ratio (eoy) x-33.076.447.815.313.4 
Price / Book Value ratio x3.16.67.72.02.2 
Dividend payout %00000 
Avg Mkt Cap Rs m61139194254298 
No. of employees `000NANANANANA 
Total wages/salary Rs m1210193473 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
DECIPHER LABS INCOME DATA
Net Sales Rs m41081240556 
Other income Rs m01036 
Total revenues Rs m41181243562 
Gross profit Rs m-2142535 
Depreciation Rs m00068 
Interest Rs m000812 
Profit before tax Rs m-2241521 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00047 
Profit after tax Rs m-2241114 
Gross profit margin %-49.26.85.610.56.3 
Effective tax rate %008.024.934.5 
Net profit margin %-49.218.05.04.62.5 
DECIPHER LABS BALANCE SHEET DATA
Current assets Rs m43063227225 
Current liabilities Rs m6838213173 
Net working cap to sales %-62.3208.431.05.69.4 
Current ratio x0.63.51.71.11.3 
Inventory Days Days2,1601111777 
Debtors Days Days1,3162,1121,5662,224766 
Net fixed assets Rs m2200127161 
Share capital Rs m808080101101 
"Free" reserves Rs m-61-59-552536 
Net worth Rs m192125126137 
Long term debt Rs m000067 
Total assets Rs m263063353387 
Interest coverage x0074.52.92.8 
Debt to equity ratio x00000.5 
Sales to assets ratio x0.10.31.30.71.4 
Return on assets %-7.26.26.55.36.7 
Return on equity %-9.58.616.08.810.2 
Return on capital %-9.38.617.717.816.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
DECIPHER LABS CASH FLOW
From Operations Rs m -0 -1 2 -152 18 
From Investments Rs m 0 0 -0 -1 -3 
From Financial Activity Rs m 0 1 1 164 40 
Net Cashflow Rs m 0 -0 3 12 55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 34.2%
Institution 0.1%
Non-Institution 65.8%
Total 100.0%
Free Float 65.8%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Plot No. 94 4th Floor, Road No. 2 Sagar Society, Banjara Hills, Hyderabad - 500034
E-mail info@decipherlabs.in Web http://www.decipherlabs.in/
Tel 040-48536100 Fax
Sector PHARMACEUTICALS Group MNC
Tr Agent Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
COMP SEC: Kumar Raghavan YEAR OF INC: 1986 BSE CODE: 524752 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare DECIPHER LABS With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Views on news

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DECIPHER LABS

  • Track your investment in DECIPHER LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DECIPHER LABS

DECIPHER LABS 8-QTR ANALYSIS

COMPARE DECIPHER LABS WITH

MARKET STATS